ReviewHematology, transfusion and cell therapy2024

Venetoclax with low-dose cytarabine, a forgotten combination in patients with acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review.

Lauro Fabián Amador-Medina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.